GlassScriptPhysician profile
Titorya T Stover
NPI 1053670786
$2,163.76
in general payments reported to CMS, 2019-2025
23 companies · $626 in 2025
The $626 reported for 2025 was more than what a typical Sports Medicine (Podiatrist) provider received nationally (typical 2025 total: $307).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $173 · 2021: $351 · 2022: $253 · 2023: $203 · 2024: $241 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $485.47 | 2019-2025 | Stravix Pl, Grafix Pl, Stravix |
| Organogenesis INC. | $250.98 | 2019-2025 | Apligraf |
| Paratek Pharmaceuticals, INC. | $243.62 | 2022-2025 | Nuzyra |
| Stryker Corporation | $175.69 | 2021-2025 | Allograft Bio-Implants, Citrefix, Prostep Mica |
| Horizon Therapeutics Plc | $172.35 | 2019-2023 | Krystexxa |
| Medtronic, INC. | $157.94 | 2021 | |
| Osiris Therapeutics INC. | $128.53 | 2019 | |
| Integra Lifesciences Corporation | $123.42 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $85.45 | 2025 | |
| Bioventus LLC | $70.77 | 2024-2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Boston Scientific Corporation | $47.06 | 2020-2023 | Wavewriter Alpha Prime 16 |
| Kci USA, INC. | $32.77 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $22.84 | 2024 | Exparel |
| Acell, INC. | $21.36 | 2019 | |
| Urgo Medical North America, LLC | $20.90 | 2025 | Urgoclean Ag |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $20.65 | 2025 | Activ.A.C. |
| Next Science LLC | $19.24 | 2023 | Blastx, Surgx, Xperience |
| Biocomposites INC | $15.36 | 2020 | |
| Abbvie INC. | $14.56 | 2021 | |
| Merck Sharp & Dohme LLC | $14.24 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $13.78 | 2021 | |
| Amgen INC. | $13.58 | 2024 | Krystexxa |
| Zyla Life Sciences, INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Titorya Stover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.